Abstract
PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have